Wednesday, June 4, 2008

P1: Dialysis Access: Creation and Maintenance 2008
SDCC: Room 16AB

Supported by an educational grant from Bard Peripheral Vascular, Inc.

Moderator: Anton N. Sidawy, MD
VA Medical Center, Washington, D.C.

At the end of this session, participants should be able to:

1. Understand and determine the socioeconomic issues related to AV dialysis access including reimbursement.
2. Learn complex AV accesses and their placement.
3. Understand issues surrounding the management of failed access and other complications.

7:00 am
Practice Guidelines in AV Access
Anton N. Sidawy, MD, VA Medical Center, Washington, D.C.

7:10 am
The Study of Evidence: How Is it Applied to AV Access Management?
Mohamed B. Elamin, MBBS, Mayo Clinic, Rochester, Minn.

7:20 am
Autogenous Access First and Surveillance: What Does the Evidence Indicate?
Adnan Z. Rizvi, MD, Mayo Clinic, Rochester, Minn.

7:30 am
AV Access Centers: Do They Make a Difference?
Krishna M. Jain, MD, Advanced Vascular Surgery, Kalamazoo, Mich.

7:40 am
Reimbursement for AV Access Procedures: 2008 and Beyond
Sean P. Roddy, MD, The Vascular Group, PLLC, Albany, N.Y.

7:50 am
Keynote Presentation
1976, The Year the Upper Arm Fistula Was "Born:" A Historical Perspective
Fuad J. Dagher, MD, VA Medical Center, Washington, D.C.

8:05 am
Break

8:15 am
The Role of Anti-Platelets and Other Anticoagulants in AV Access: Do They Make a Difference?
Thomas S. Huber, MD, University of Florida, Gainesville, Fla.

8:25 am
Complex Vascular Accesses: Which One Is Worth Considering When All Others are Exhausted?
David L. Cull, MD, Upstate Vascular Associates, Greenville, S.C.

8:35 am
Femoral Vein Transposition: Is it a Useful Conduit for AV Access Construction, and How Can it be Maximized?
Wayne S. Gradman, MD, Triangle Surgery Center, Beverly Hills, Calif.

8:45 am
Access too Deep: How Can it be Transformed Into a Functional Access?
Ruth L. Bush, MD, Scott & White Hospital & Clinic, Texas A & M University, Health Science Center, Temple, Texas

8:55 am
The Infected Vascular Access: When Can the AV Access be Saved?
Matthew J. Dougherty, MD, Pennsylvania Vascular Associates, Philadelphia, Pa.

9:05 am
Ischemic Steal Syndrome: Can it be Predicted and Can the AV Access be Saved?
Samuel E. Wilson, MD, UC Irvine Healthcare, Orange, Calif.

9:15 am
Failure to Mature: How Can it be Managed for Optimal Access Functionality?
George H. Meier, MD, University of Cincinnati School of Medicine, Cincinnati, Ohio

9:25 am
Panel Discussion

Moderators:
Michael R. Jaff, DO, FACP, FACC
Harvard Medical School, Massachusetts General Hospital, Boston, Mass.

Glenn M. LaMuraglia, MD
Massachusetts General Hospital, Boston, Mass.

At the end of this session, participants should be able to:

1. Appreciate the impact of lipid-lowering therapy in patients with peripheral vascular disease, as well as reviewing the role of specific lipid lowering treatments.
2. Develop an algorithm for the use of specific antiplatelet agents in peripheral arterial disease, with an in-depth understanding of the mechanisms of action of these agents.
3. Learn about the most common hypercoagulable syndromes in vascular disease, and organize a comprehensive hypercoagulable laboratory profile to use in clinical practice.
4. Develop an understanding of some of the preferred and useful drugs for treatment of the usual co-morbid conditions of patients with peripheral vascular disease and how they may affect surgical care.

7:00 am 
What Is the Big Deal with Hypercholesterolemia in Peripheral Vascular Disease?
Michael S. Conte, MD, Brigham & Women's Hospital, Boston, Mass.

7:20 am 
Modern Treatment Strategies for Hyperlipidemia: What Are the Drugs and Which Ones Should You Use?
Richard V. Milani, MD, FACC, Ochsner Medical Institutions, New Orleans, La.

7:40 am
Platelets and Peripheral Arterial Disease: Importance, Antiplatelet Therapy, PDE 3 Inhibitors – Efficacy, Combination Therapy, Duration
David L. Dawson, MD, UC Davis Vascular Center, Sacramento, Calif.

8:00 am
Hypercoagulability in Vascular Disease: When Should You Consider This, and What Tests Should You Order?
Michael Laposata, MD, PhD, Vanderbilt University Medical Center, Nashville, Tenn.

8:25 am
New Antithrombotic Agents for Vascular Disease—Bivalirudin, Argatroban and Future Developments
Joseph A. Caprini, MD, Evanston Northwestern Healthcare, Glenview, Ill.

8:40 am
What Are some of the Preferred Cardioprotective Medications Patients for Patients with PVD: Are There Others that Should be Avoided?
Peter K. Henke, MD, University of Michigan Health System, Ann Arbor, Mich.

8:55 am
Tobacco and Vascular Disease: Can We Ever Get Our Patients to Stop?
James H. Black, MD, Johns Hopkins Hospital, Baltimore, Md.

9:10 am
Exercise Therapy in Peripheral Arterial Disease: How Does this Work, and What Prescriptions Should We Give Our Patients?
Michael R. Jaff, DO, FACP, FACC, Harvard Medical School, Massachusetts General Hospital, Boston, Mass.

9:25 am 
Questions and Answers

9:45 am
Case Presentations
Panel

P3: Superficial, Perforator and Deep Vein Disease: You Tell Us Where to Go
SDCC: Room 16AB

Moderator: Steve M. Elias, MD
Englewood Hospital and Medical Center, Center for Vein Disease, Englewood, N.J.

At the end of this session, participants should be able to:

1. Learn the algorithm for the management of combined multi-system level venous disease.
2. Be aware of the unresolved and controversial topics in vein disease treatment.
3. Be exposed to the methods by which they can expand their practice options when treating venous disease. 

Finally, a Postgraduate Course that is different. The audience tells us what to do. Each faculty participant will have two to three short talks available. However, the attendees decide where we start, where we go and what we cover. Almost all aspects of vein disease will be represented, but we will only address the issues that the audience deems most important and relevant. This will be an interactive session with the audience contributing as much as the faculty. We think you will enjoy the session. Don't just sit back and listen.    
 
Peter Gloviczki, MD, Mayo Clinic, Rochester, Minn.
Mark H. Meissner, MD, University of Washington Medical Center, Seattle, Wash.
Thomas O'Donnell, MD, Tufts - New England Medical Center, Boston, Mass.
Marc A. Passman, MD, University of Alabama at Birmingham, Birmingham, Ala.
Joseph Raffetto, MD, VA Boston Healthcare System, West Roxbury, Mass.
Mel Rosenblatt, MD, Connecticut Image Guided Surgery, Fairfield, Conn.
Julianne Stoughton, MD, Winchester Hospital and Massachusetts General Hospital, Stoneham, Mass.

Moderator: Gregory L. Moneta, MD
Oregon Health Sciences University, Portland, Ore.

At the end of this session the participant should be able to:

1. Improve their coding of vascular laboratory examinations to both optimize reimbursement and be in compliance with Medicare regulations.
2. Begin to formulate plans for automating and expanding the vascular laboratory to potentially offer services beyond traditional physiologic testing and ultrasound imaging.
3. Develop a plan for obtaining physician certification in interpreting noninvasive vascular laboratory studies.
4. Prepare a plan for accrediting your vascular laboratory to maximize your qualifications for hospital credentialing purposes and receiving reimbursement in the coming era of pay for performance.

Part A
10:30 am     
Introduction
Gregory L. Moneta, MD, Oregon Health Sciences University, Portland, Ore.

10:35 am     
Training Residents in Vascular Laboratory Interpretation
Gregory L. Moneta, MD, Oregon Health Sciences University, Portland, Ore.
 
10:50 am     
Certifying Physicians in Vascular Laboratory Interpretation: Should You Take the Test?
R. Eugene Zierler, MD, University of Washington, Seattle, Wash.

11:05 am     
Accrediting the Vascular Laboratory: Why Bother?
Sandra L. Katanick, CAE, The Intersocietal Commission for the Accreditation of Vascular Laboratories, Columbia, Md.

11:20 am
Debate: Who Should Run a Vascular Laboratory?
Debate Position 1: Vascular Surgeons Should Run Vascular Laboratories
Dennis Bandyk, MD, University of South Florida, Tampa, Fla.
                       
11:30 am
Debate Position 2: Vascular Surgeons Should Operate and Non-surgical Physicians Should Run Vascular Laboratories
Michael R. Jaff, DO, FACP, FACC, Harvard Medical School, Massachusetts General Hospital, Boston, Mass.
              
Debate Rebuttal

11:35 am     
Panel Discussion

11:50 am     
Break

Part B
Noon     
Reimbursement Issues: How Are We Doing and What’s New for 2007 and 2008?
Sean P. Roddy MD, The Vascular Group, Albany, N.Y.

12:15 pm     
Automating the Vascular Lab: Lessons Learned
Byron E. Williams BS, RVT, Oregon Health Sciences University, Portland, Ore.

12:30 pm     
Training and Retention of Vascular Technologists: How to Get Them and How Do You Keep Them?
Donna Blackburn, MS, RN, RVT, Northwestern University, Chicago, Ill.
     
12:45 pm     
Setting Up an Imaging Center: Adding CT, MR and an Outpatient Angiography Suite to Surgeon-Run Vascular Laboratories
Russell Samson, MD, Florida State University Medical School, Sarasota, Fla.

1:00 pm     
The Vascular Laboratory Is More than Just for Imaging: Duplex Guided Angioplasty in the Office
Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, N.Y.

1:15 pm
Panel Discussion

Vascular Annual Meeting Registration Opens
SDCC: Hall B1 Lobby

P5: Advanced Endovascular Procedures: Are There Limits to the Scope of Our Endovascular Practice? 
SDCC: Room 16AB

Supported by an educational grant from Medtronic.

Moderator: Peter H. Lin, MD,
Baylor College of Medicine, Houston, Texas

At the end of this session, participants should be able to:

1. Understand the role of microcatheter techniques and microembolization in the treatment of vascular disease.
2. Be familiar with complex interventional techniques in endovascular procedures.
3. Have insight into potential applications of endovascular techniques in non-traditional vascular procedures. 

2:30 pm
Introduction
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

2:35 pm
Endovascular Approaches to Supra-aortic Trunk Lesions – Technical Considerations
Mark K. Eskandari, MD, Northwestern University School of Medicine, Chicago, Ill.

2:45 pm
Selective Mesenteric Catheterization for Endoleak Management
W. Anthony Lee, MD, University of Florida, Gainesville, Fla.

2:55 pm
Translumbar Interventions for Endoleak Management
Bart Muhs, MD, Yale University School of Medicine, New Haven, Conn.

3:05 pm
Endovascular Intervention for Pulmonary Embolism and Superior Vena Cava Syndrome
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

3:15 pm
Tibial Artery Interventions – Indications, Tips and Techniques
Sean P. Lyden, MD, Cleveland Clinic, Cleveland, Ohio

3:25 pm
Panel Discussion

3:45 pm
Break

4:00 pm
Endovascular Treatment of AV Malformation
Robert R. Mendes, MD, University of North Carolina, Chapel Hill, N.C.

4:10 pm
Catheter-Based Mesenteric Interventions for GI Bleeding and Hepatic Chemoembolization
Panagiotis Kougias, MD, Baylor College of Medicine, Houston, Texas

4:20 pm
TIPS – Indications and Techniques
Darren B. Schneider, MD, University of California San Francisco, Calif.

4:30 pm
Endovascular Management of Varicocele and Pelvic Congestion Syndrome
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

4:40 pm
Uterine Fibroid Embolization – Indications, Tips and Techniques
Michael B. Silva, Jr., MD, University of Texas Medical Branch, Galveston, Texas

4:50 pm
Panel Discussion

P6: Emergencies in Vascular and Endovascular Surgery 
SDCC: Room 17AB

Supported by an educational grant from W.L. Gore & Associates, Inc.

Moderator: Benjamin W. Starnes, MD, FACS
University of Washington, Seattle, Wash.

At the end of this session, participants should be able to:

1. Understand contemporary management of vascular emergencies utilizing open and endovascular techniques.
2. Understand the technological limitations of specialized approaches for the management of vascular emergencies.
3. Have insight into potential applications of open, endovascular, or hybrid techniques in the management of vascular emergencies.

2:30 pm
Opening Remarks
Benjamin W. Starnes, MD, FACS, University of Washington, Seattle, Wash.

2:40 pm
Open Repair of Ruptured AAA
Michael Belkin, MD, Brigham and Women’s Hospital, Boston, Mass.

2:50 pm
Endovascular Repair of Ruptured AAA
Manish Mehta, MD, The Vascular Group PLLC, Albany, N.Y.

3:00 pm
Management of Blunt Aortic Injury to the Thoracic Aorta – A Review of Contemporary Data
Mark K. Eskandari, MD, Northwestern University, Feinberg School of Medicine, Chicago, Ill.

3:10 pm
Management of Blunt Aortic Injury to the Thoracic Aorta – Technical Tips
Mark A. Farber, MD, UNC Vascular Surgery, Chapel Hill, N.C.

3:20 pm
Endovascular Management of Complicated Type B Aortic Dissections
Joseph V. Lombardi, MD, Thomas Jefferson University, Philadelphia, Pa.
 
3:30 pm
Panel Discussion

4:00 pm
Break

4:15 pm
Extremity Vascular Trauma
David L. Gillespie, MD, Walter Reed Army Medical Center, Washington, D.C.

4:25 pm
Use of Lytic Therapy for Acute Lower Extremity Ischemia
Fred A. Weaver, MD, Keck School of Medicine of the University of Southern California, Los Angeles, Calif.

4:35 pm
Acute Mesenteric Ischemia – Endovascular Management
Sean P. Lyden, MD, Cleveland Clinic Foundation, Cleveland, Ohio
 
4:45 pm
Acute Vascular Emergencies Related to Substance Abuse
Nam T. Tran, MD, University of Washington, Seattle, Wash.

4:55 pm
Panel Discussion

3:00 pm
Welcome and Introduction
K. Wayne Johnston, MD
Toronto General Hospital, Toronto, Ontario, Canada

Gregorio Sicard, MD
Washington University, St. Louis, Mo.

At the end of this session, the participant should be able to:

1. Understand the benefits of the most promising endovascular techniques for aortic reconstructions.
2. Select the best diagnostic tests for complex aortic repairs.
3. Decide on correct indications for several endovascular and open surgical procedures for lower extremity peripheral arterial disease.
4. Understand the differences and challenges in the education of vascular specialists at different continents. 

3:05 pm 
Presidential Address: The WFVS
Peter Gloviczki, MD
Mayo Clinic, Rochester, Minn.

3:20 pm
The Future of Vascular Surgery in the World – Now!
Moderators: Enrico Ascher, MD
Maimonides Medical Center, Brooklyn, N.Y.

Henrik Sillesen, MD
University of Copenhagen, Denmark

Chairs:
John Harris, MD
Royal Prince Alfred Hospital, New South Wales, Australia

Hiroshi Shigematsu, MD
Tokyo Medical University, Tokyo, Japan

3:20 pm
Australia/New Zealand 
The Future of Vascular Surgery – An Australian Perspective
Philip J. Walker, MD, FRACS, Royal Brisbane & Women’s Hospital, Queensland, Australia 

3:32 pm
Europe  
Laparoscopic Surgery in Europe
Jean-Baptiste Ricco, MD, University Hospital, Poitiers, France

3:44 pm
India  

Autologus Bone Marrow Stem Cell Therapy for Buerger’s Disease
Vishnu Motukuru, MD, Jain Institute of Vascular Sciences, Bangalore, India

3:56 pm
Japan
Endovascular Repair for Patients of Thoracic Aortic Aneurysms: Fenestrated and Scallop Stent Grafts for Distal Arch Aneurysms
Satoshi Kawaguchi, MD, Tokyo Medical University, Tokyo, Japan

4:08 pm
South Africa  
The Role of the Medial Head of the Gastrocnemius Muscle in Causing Functional Popliteal Artery Entrapment
J. Pillai, MD, University of the Witwatersrand, Johannesburg, South Africa

4:20 pm
South America
Early Experience with Branched Devices for Thoracoabdominal Aneurysm Repair  
Luiz Lanziotti, MD, Endovascular Techniques Integrated Service, Rio de Janeiro, Brazil.

4:32 pm
United States
Complex Aortic Disease – Changes in Perception, Evaluation and Management
Roy K. Greenberg, MD, Cleveland Clinic, Cleveland, Ohio

4:45 pm
Coffee Break
SDCC: Room 15AB Foyer

5:00 pm
Robert B. Rutherford Lecture – Which Is the Best Revascularization for Critical Limb Ischemia—Endovascular or Open Surgery?
Jonathan D. Beard, MD, PhD
Sheffield Vascular Institute, United Kingdom
 
Introduction: K. Craig Kent, MD
New York Presbyterian Hospital, New York, N.Y.

5:20 pm 
Education in Vascular Surgery: Critical Issues around the Globe
Moderators: Jack L. Cronenwett, MD
Dartmouth-Hitchcock Clinic, Lebanon, N.H.

Christos Liapis, MD
Athens University Medical School, Athens, Greece

Chairs: Kumud Rai, MD
Max Heart & Vascular Institute, New Delhi, India

Martin Veller, MD
University of the Witwatersrand, Johannesburg, South Africa

5:20 pm
Australia/New Zealand 
Alan Scott, MD, FRCS, FRACS, Royal Australasian College of Surgeons, Melbourne, Australia

5:29 pm
Europe
Johan Hajo van Bockel, MD, Uppsala University Hospital, Uppsala, Sweden

5:38 pm
India  
Sekar Natarajan, MD, Apollo Hospitals ,Chennai, India.

5:47 pm
Asia
Sopon Jirasirithum MD, Ramathibodi Hospital Medical School, Mahidol University, Bangkok, Thailand

5:56 pm
South Africa  
Martin Veller, MD, University of the Witwatersrand, Johannesburg, South Africa

6:05 pm
South America
Ricardo Moreira, MD, Federal University, Parana, Brazil

6:14 pm
United States
Joseph L. Mills, MD, University of Arizona, Tucson, Ariz.

6:23 pm 
Panel Discussion

6:55 pm
Presentation of Next WFVS President and Announcement of Next Meeting Site
Peter Gloviczki, MD
Mayo Clinic, Rochester, Minn.

7:00 pm
Adjourn